Home
NSE: VALIANTLAB
Market Cap
NSE: VALIANTLAB
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 112.5 | 101.9 | 119 | 101.9 |
13 Jan 2025 | 101.4 | 108.25 | 108.25 | 99.35 |
10 Jan 2025 | 109.15 | 116 | 116 | 105.55 |
09 Jan 2025 | 107.85 | 111.6 | 111.6 | 105.9 |
08 Jan 2025 | 108.8 | 115.5 | 115.5 | 108.45 |
07 Jan 2025 | 110.25 | 109.05 | 111.05 | 109.05 |
06 Jan 2025 | 108.45 | 116.9 | 116.9 | 108.15 |
03 Jan 2025 | 112.9 | 111.85 | 116.2 | 111.85 |
02 Jan 2025 | 114.25 | 114.9 | 114.9 | 112.1 |
01 Jan 2025 | 111.5 | 114.9 | 114.9 | 111.2 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 112.5 |
13 Jan 2025 | 101.4 |
10 Jan 2025 | 109.15 |
09 Jan 2025 | 107.85 |
08 Jan 2025 | 108.8 |
07 Jan 2025 | 110.25 |
06 Jan 2025 | 108.45 |
03 Jan 2025 | 112.9 |
02 Jan 2025 | 114.25 |
01 Jan 2025 | 111.5 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical P/E Ratio of Valiant Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical Revenue of Valiant Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical EBITDA of Valiant Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical Net Profit of Valiant Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Net loss of Valiant Laboratories reported to Rs 0.51 crore in the quarter ended June 2024 as against
Read more
2024-08-13 00:00:00
Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.
Read more
2024-08-09 00:00:00
Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 November 202
Read more
2024-11-08 00:00:00
Net loss of Valiant Laboratories reported to Rs 4.74 crore in the quarter ended September 2024 as ag
Read more
2024-11-13 00:00:00